Nitric oxide synthase-cyclo-oxygenase pathways in organum vasculosum laminae terminalis: possible role in pyrogenic fever in rabbits

Br J Pharmacol. 1996 May;118(1):179-85. doi: 10.1111/j.1476-5381.1996.tb15383.x.

Abstract

1. Fever was induced in rabbits by administration of Escherichia coli endotoxin (lipopolysaccharide; LPS; 0.001-10 micrograms) into the organum vasculosum laminae terminalis (OVLT). Deep body temperature was evaluated over a period of 7 h. 2. The LPS-induced febrile response was mimicked by intra-OVLT injection of the nitric oxide (NO) donors, S-nitroso-acetylpenicillamine (SNAP, 1-10 micrograms), sodium nitroprusside (SNP, 50 micrograms), or hydroxylamine (10 micrograms), the cyclic GMP analogue 8-bromo-cyclic GMP (8-Br-cyclic GMP, 10-100 micrograms), or prostaglandin E2 (PGE2, 0.2 micrograms). 3. Dexamethasone (Dex, a potent inhibitor of the transcription of inducible NO synthase, iNOS, 10 micrograms), anisomycin (a protein synthesis inhibitor, 100 micrograms), L-N5-(1-iminoethyl)ornithine (L-NIO; an irreversible NOS inhibitor, 10-200 micrograms), aminoguanidine (a specific iNOS inhibitor, 1000 micrograms), or NG-methyl-L-arginine acetate (L-NMMA, a NOS inhibitor, 100 micrograms) inhibited fever induced by LPS when injected into the OVLT 1 h before LPS injection. An intra-OVLT dose of 1000 micrograms of NG-nitro-L-arginine methyl ester (L-NAME, a potent inhibitor of constitutive NOS) did not exhibit antipyretic effects. 4. Methylene blue (an inhibitor of NOS and soluble guanylate cyclase, 1-10 micrograms), 6-(phenylamino)-5,8-quinolinedione (LY-83583; an inhibitor of soluble guanylate cyclase and NO release, 20 micrograms), or indomethacin (an inhibitor of cyclo-oxygenase, COX, 400 micrograms) inhibited fever induced by LPS when injected into the OVLT 1 h before LPS injection. Pretreatment with methylene blue or haemoglobin (a NO scavenger, 100 micrograms) attenuated the fever induced by intra-OVLT injection of SNAP. 5. The PGE2-induced fever was potentiated, rather then attenuated, by pretreatment with an intra-OVLT dose of animoguanidine (1000 micrograms), L-NMMA (100 micrograms) or L-NIO (200 micrograms). 6. These results suggest that iNOS-COX pathways in the OVLT represent an important mechanism for modulation of pyrogenic fever in rabbits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Temperature Regulation / drug effects
  • Cyclic GMP / antagonists & inhibitors
  • Cyclic GMP / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Dinoprostone / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Fever / chemically induced*
  • Fever / enzymology*
  • Guanylate Cyclase / antagonists & inhibitors
  • Hypothalamus / enzymology*
  • Hypothalamus / physiology
  • Indomethacin / pharmacology
  • Lipopolysaccharides / toxicity
  • Male
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase / physiology*
  • Prostaglandin-Endoperoxide Synthases / physiology*
  • Rabbits

Substances

  • Cyclooxygenase Inhibitors
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Prostaglandin-Endoperoxide Synthases
  • Guanylate Cyclase
  • Cyclic GMP
  • Dinoprostone
  • Indomethacin